| |
| |
| Exchange: |
New York Stock Exchange |
| Security
Type: |
Common |
| Shares
Out: |
2,250,000,000 |
| Market
Cap: |
111.92(B) |
| Last
Volume: |
7,770,352 |
Avg
Vol: |
12,048,492 |
| 52
Week Range: |
$39.66 - $59.16 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Drug Manufacturers - Major |
|
Member Indexes:
|
| |
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
| |
S&P 100 |
|
S&P 500 |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 243 |
| Guru Rank Value : 6.6 |
| Guru Occurances : 3 |
|
|
|
|
|
| |
|
Company Profile Bristol-Myers Squibb is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceutical products on a global basis. Co.'s primary products include: Revlimid®, in which Revlimid (lenalidomide) is an oral immunomodulatory drug that in combination with dexamethasone is indicated for the treatment of patients with multiple myeloma; and Eliquis®, in which Eliquis (apixaban) is an oral Factor Xa inhibitor indicated for the reduction in risk of stroke/systemic embolism in non-valvular atrial fibrillation and for the treatment of DVT/PE and reduction in risk of recurrence following initial therapy.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
13,571 |
13,571 |
| Total Buy Value |
$0 |
$0 |
$672,994 |
$672,994 |
| Total People Bought |
0 |
0 |
2 |
2 |
| Total Buy Transactions |
0 |
0 |
3 |
3 |
| Total Shares Sold |
0 |
0 |
0 |
407,446 |
| Total Sell Value |
$0 |
$0 |
$0 |
$29,947,917 |
| Total People Sold |
0 |
0 |
0 |
4 |
| Total Sell Transactions |
0 |
0 |
0 |
8 |
| End Date |
2024-06-20 |
2024-03-19 |
2023-09-19 |
2022-09-19 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Dubow Adam |
SVP,ChiefCompliance&EthicsOff. |
• – – |
2020-03-10 |
4 |
D |
$57.93 |
$116,150 |
D/D |
(2,005) |
19,286 |
|
- |
|
| Dubow Adam |
SVP,ChiefCompliance&EthicsOff. |
• – – |
2020-03-10 |
4 |
A |
$0.00 |
$0 |
D/D |
561 |
20,363 |
|
- |
|
| Dubow Adam |
SVP,ChiefCompliance&EthicsOff. |
• – – |
2020-03-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,007 |
20,091 |
|
- |
|
| Dubow Adam |
SVP,ChiefCompliance&EthicsOff. |
• – – |
2020-03-10 |
4 |
D |
$0.00 |
$0 |
D/D |
(26) |
16,697 |
|
- |
|
| Leung Sandra |
EVP, General Counsel |
• – – |
2020-03-10 |
4 |
D |
$57.93 |
$1,640,114 |
D/D |
(28,312) |
574,164 |
|
- |
|
| Leung Sandra |
EVP, General Counsel |
• – – |
2020-03-10 |
4 |
A |
$0.00 |
$0 |
D/D |
5,096 |
591,284 |
|
- |
|
| Leung Sandra |
EVP, General Counsel |
• – – |
2020-03-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
51,598 |
588,175 |
|
- |
|
| Leung Sandra |
EVP, General Counsel |
• – – |
2020-03-10 |
4 |
D |
$0.00 |
$0 |
D/D |
(298) |
555,623 |
|
- |
|
| Elicker John E |
EVP, Investor Relations |
• – – |
2020-03-10 |
4 |
D |
$57.93 |
$455,330 |
D/D |
(7,860) |
70,946 |
|
- |
|
| Elicker John E |
EVP, Investor Relations |
• – – |
2020-03-10 |
4 |
A |
$0.00 |
$0 |
D/D |
1,835 |
76,240 |
|
- |
|
| Elicker John E |
EVP, Investor Relations |
• – – |
2020-03-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
18,407 |
75,102 |
|
- |
|
| Elicker John E |
EVP, Investor Relations |
• – – |
2020-03-10 |
4 |
D |
$0.00 |
$0 |
D/D |
(102) |
62,741 |
|
- |
|
| Caforio Giovanni |
Chairman and CEO |
• • – |
2020-03-10 |
4 |
D |
$57.93 |
$6,774,508 |
D/D |
(116,943) |
485,424 |
|
- |
|
| Caforio Giovanni |
Chairman and CEO |
• • – |
2020-03-10 |
4 |
A |
$0.00 |
$0 |
D/D |
20,877 |
556,936 |
|
- |
|
| Caforio Giovanni |
Chairman and CEO |
• • – |
2020-03-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
211,796 |
544,032 |
|
- |
|
| Caforio Giovanni |
Chairman and CEO |
• • – |
2020-03-10 |
4 |
D |
$0.00 |
$0 |
D/D |
(1,190) |
409,368 |
|
- |
|
| Judge Ann Powell |
EVP, Chief Human Resources |
• – – |
2020-03-10 |
4 |
D |
$57.93 |
$837,784 |
D/D |
(14,462) |
51,452 |
|
- |
|
| Judge Ann Powell |
EVP, Chief Human Resources |
• – – |
2020-03-10 |
4 |
A |
$0.00 |
$0 |
D/D |
3,093 |
60,328 |
|
- |
|
| Judge Ann Powell |
EVP, Chief Human Resources |
• – – |
2020-03-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
31,169 |
58,421 |
|
- |
|
| Judge Ann Powell |
EVP, Chief Human Resources |
• – – |
2020-03-10 |
4 |
D |
$0.00 |
$0 |
D/D |
(174) |
37,926 |
|
- |
|
| Schmukler Louis S |
EVP,Pres.,Glob.Prod. & Supply |
• – – |
2020-03-10 |
4 |
D |
$57.93 |
$784,372 |
D/D |
(13,540) |
51,777 |
|
- |
|
| Schmukler Louis S |
EVP,Pres.,Glob.Prod. & Supply |
• – – |
2020-03-10 |
4 |
A |
$0.00 |
$0 |
D/D |
3,019 |
60,186 |
|
- |
|
| Schmukler Louis S |
EVP,Pres.,Glob.Prod. & Supply |
• – – |
2020-03-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
30,519 |
58,379 |
|
- |
|
| Schmukler Louis S |
EVP,Pres.,Glob.Prod. & Supply |
• – – |
2020-03-10 |
4 |
D |
$0.00 |
$0 |
D/D |
(184) |
38,805 |
|
- |
|
| Bancroft Charles A |
EVP, Head of Integration |
• – – |
2020-03-10 |
4 |
D |
$57.93 |
$1,930,286 |
D/D |
(33,321) |
137,534 |
|
- |
|
960 Records found
|
|
Page 14 of 39 |
|
|
0.25 (0.51%) 
